返回 Agenda
Session 5, Track B: Optimizing Clinical Trials Operationally in Canada
Session Chair(s)
Marie-France Goyer, MSc
Director, Clinical Operations
Abcellera, Canada
Émilie Lévesque, MSc
Senior Clinical Quality Manager
Abcellera, Canada
Lorella Garofalo, PhD
Head of Regulatory Sciences
Pfizer Canada, Canada
There is currently high interest by Canadian stakeholders, including government, to strengthen the clinical trials ecosystem in Canada. This presents a unique opportunity to further evolve and grow medical innovation as well as support patient care through clinical research. At the same time, there are new challenges in this sector. This session will provide an overview of ongoing initiatives as well as resources available for clinical research professionals and organizations to respond to opportunities and challenges as well as to maximize the success of their clinical research efforts.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify challenges related to advancing clinical research in Canada
- Recognize the resources available to support various aspects of clinical research
Speaker(s)
Supporting Canadian Clinical Research Excellence Through Collaboration
Rebecca Barnes, MS
Network of Networks (N2), Canada
Executive Director
Speaker
Bruno J Battistini, PhD, MS, MSc
CANTRAIN, Canada
National Executive Director and Chief Operating Officer
Introduction to Biopharmaceutical Manufacturing
Sven Ansorge, PhD
CASTL Canada, Canada
Associate Director of Technical Training